UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Major lung complications of systemic sclerosis (vol 14, pg 511, 2018)

Denton, CP; Wells, AU; Coghlan, JG; (2018) Major lung complications of systemic sclerosis (vol 14, pg 511, 2018). [Corrigendum]. Nature Reviews Rheumatology , 14 (11) p. 682. 10.1038/s41584-018-0108-3. Green open access

[thumbnail of NRR final accepted text for UCL 2018-Denton-Wells-Coghlan-with minor correction Table 2.pdf]
Preview
Text
NRR final accepted text for UCL 2018-Denton-Wells-Coghlan-with minor correction Table 2.pdf - Accepted Version

Download (500kB) | Preview

Abstract

Systemic sclerosis (SSc) is associated with high mortality owing to internal organ complications and lung disease is the leading cause of SSc-associated death. The most notable lung complications in SSc are fibrosis and pulmonary arterial hypertension (PAH). A major challenge for the management of lung disease in SSc is detecting those patients with severe pathology and those patients that are likely to benefit from available treatments. In the past few, strategies for managing lung fibrosis and pulmonary hypertension, including PAH, have greatly progressed. For lung fibrosis, the tools to assess risk of progression and severity of the disease have been refined. Clinical trial results support the use of immunosuppression, including high intensity regimens with autologous stem cell transplantation. New trials are underway to test other potential therapies including treatments that are approved for use in idiopathic lung fibrosis. For PAH, identifying individuals at high risk of disease development is critical. In addition, individuals who have borderline elevation of pulmonary arterial pressure need to be appropriately managed and followed up. Many approved drugs targeting PAH are now available and results from large-scale clinical trials provide robust evidence that various treatments for SSc-associated PAH are associated with good long-term outcomes.

Type: Article
Title: Major lung complications of systemic sclerosis (vol 14, pg 511, 2018)
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41584-018-0108-3
Publisher version: https://doi.org/10.1038/s41584-018-0062-0
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10064309
Downloads since deposit
25Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item